Lv3
262 积分 2025-10-05 加入
MASLD as a systemic metabolic disease: expanding the scope of cardiovascular-kidney-metabolic (CKM) syndrome
1个月前
已完结
Prediction of the individual risk for the development of brain metastases in patients with non‐oncogene‐addicted non‐small cell lung cancer: Real‐world data from the German prospective CRISP registry (AIO‐TRK‐0315)
2个月前
已完结
Awareness of Human Papillomavirus (HPV), Increasing Rates of Oropharyngeal Cancer, and Estimated Economic Burden in Denmark
2个月前
已完结
Development and Release of the Munich UICC Staging Tool ( MUST ): Advancing UICC Staging in Real‐World Data With Insights From Pancreatic and Stomach Cancer
2个月前
已完结
A Tumor-Homing Nanoframework for Synergistic Microwave Tumor Ablation and Provoking Strong Anticancer Immunity Against Metastasis
2个月前
已完结
Progression of Liver Fibrosis and Liver-related Event Risk in Metabolic Dysfunction-associated Steatotic Liver Disease at High Cardiovascular Risk
3个月前
已关闭
Hyperferritinemia and the Risk of Liver Fibrosis and Liver-Related Events in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease
3个月前
已关闭
Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities
3个月前
已关闭
Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region
3个月前
已完结
Reply to: “Development and validation of a prognostic model for MASLD identifying hypertension as a pivotal factor: A population-based study”
3个月前
已关闭
皖公网安备34019202002308
